Healthcare Infection Control Practices Advisory Committee (HICPAC), 28221 [2013-11330]

Download as PDF Federal Register / Vol. 78, No. 93 / Tuesday, May 14, 2013 / Notices FOR FURTHER INFORMATION CONTACT: Renee Chapman, Contact Representative, or Theresa Kingsberry, Legal Assistant, Federal Trade Commission, Premerger Notification Office, Bureau Of Competition, Room H–303, Washington, DC 20580, (202) 326–3100. By Direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2013–11201 Filed 5–13–13; 8:45 am] BILLING CODE 6750–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Contact Person For More Information: Margie Scott-Cseh, Centers for Disease Control and Prevention, 1600 Clifton Road NE., M/S E–07, Atlanta, Georgia 30333, Telephone: (404) 639–8317; Email: zkr7@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2013–11331 Filed 5–13–13; 8:45 am] mstockstill on DSK4VPTVN1PROD with NOTICES Advisory Council for the Elimination of Tuberculosis Meeting (ACET) BILLING CODE 4163–18–P In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5:30 p.m., June 4, 2013; 8:30 a.m.–2:30 p.m., June 5, 2013. Place: CDC, Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333, Telephone: (404) 639–8317. This meeting is also accessible by teleconference, toll-free +1 (866) 814–3113, Participant code: 5812405. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters To Be Discussed: Agenda items include the following topics: 1) Tuberculosis (TB) prevention and control in the changing healthcare environment; 2) Drug/Diagnostic Shortages Update; 3) TB in the Homeless; 4) TB efforts along the United States/Mexico border; and 5) other tuberculosis-related issues. Agenda items are subject to change as priorities dictate. DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Mar<15>2010 16:52 May 13, 2013 Jkt 229001 Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting for the aforementioned committee: Times and Dates: 9:00 a.m.–5:00 p.m., June 5, 2013; 9:00 a.m.–12:00 p.m., June 6, 2013. Place: Centers for Disease Control and Prevention (CDC), Global Communications Center, Bldg 19, Auditorium B3, 1600 Clifton Rd., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Please register for the meeting at www.cdc.gov/ hicpac. Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 28221 Matters To Be Discussed: The agenda will include updates on CDC’s activities for healthcare associated infections (HAI), an update on draft CDC guideline for the prevention of surgical site infections and guideline for infection prevention in healthcare personnel. Also to be discussed are updates on National Healthcare Safety Network (NHSN) surveillance activities including definitions for catheter-associated urinary tract infections. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE., Mailstop A–07, Atlanta, Georgia 30333 Telephone (404) 639–4045. Email: hicpac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2013–11330 Filed 5–13–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Youth Violence Training and Technical Assistance, Funding Opportunity Announcement (FOA) CE13–1305, Initial Review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned SEP: Time and Date: 12:30 p.m.–5:00 p.m. EDT, July 24, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, E:\FR\FM\14MYN1.SGM 14MYN1

Agencies

[Federal Register Volume 78, Number 93 (Tuesday, May 14, 2013)]
[Notices]
[Page 28221]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-11330]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

    In accordance with section 10(a) (2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting for the aforementioned 
committee:
    Times and Dates: 9:00 a.m.-5:00 p.m., June 5, 2013; 9:00 a.m.-12:00 
p.m., June 6, 2013.
    Place: Centers for Disease Control and Prevention (CDC), Global 
Communications Center, Bldg 19, Auditorium B3, 1600 Clifton Rd., 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. 
Please register for the meeting at www.cdc.gov/hicpac.
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion, the 
Director, National Center for Emerging and Zoonotic Infectious Diseases 
(NCEZID), the Director, CDC, the Secretary, Health and Human Services 
regarding (1) the practice of healthcare infection prevention and 
control; (2) strategies for surveillance, prevention, and control of 
infections, antimicrobial resistance, and related events in settings 
where healthcare is provided; and (3) periodic updating of CDC 
guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters To Be Discussed: The agenda will include updates on CDC's 
activities for healthcare associated infections (HAI), an update on 
draft CDC guideline for the prevention of surgical site infections and 
guideline for infection prevention in healthcare personnel. Also to be 
discussed are updates on National Healthcare Safety Network (NHSN) 
surveillance activities including definitions for catheter-associated 
urinary tract infections.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Erin Stone, M.S., HICPAC, 
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton 
Road NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404) 639-
4045. Email: hicpac@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 2013-11330 Filed 5-13-13; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.